nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—BGLAP—blood plasma—acquired immunodeficiency syndrome	0.0614	0.244	CbGeAlD
Phylloquinone—GGCX—digestive system—acquired immunodeficiency syndrome	0.023	0.0914	CbGeAlD
Phylloquinone—BGLAP—blood—acquired immunodeficiency syndrome	0.0225	0.0893	CbGeAlD
Phylloquinone—GGCX—blood—acquired immunodeficiency syndrome	0.022	0.0871	CbGeAlD
Phylloquinone—BGLAP—bone marrow—acquired immunodeficiency syndrome	0.0218	0.0864	CbGeAlD
Phylloquinone—GGCX—vagina—acquired immunodeficiency syndrome	0.0203	0.0808	CbGeAlD
Phylloquinone—Hyperbilirubinaemia—Amprenavir—acquired immunodeficiency syndrome	0.0195	0.0261	CcSEcCtD
Phylloquinone—GGCX—lung—acquired immunodeficiency syndrome	0.0192	0.0764	CbGeAlD
Phylloquinone—Necrosis—Nevirapine—acquired immunodeficiency syndrome	0.0186	0.0248	CcSEcCtD
Phylloquinone—Inflammation—Amprenavir—acquired immunodeficiency syndrome	0.0183	0.0245	CcSEcCtD
Phylloquinone—GGCX—nervous system—acquired immunodeficiency syndrome	0.0178	0.0707	CbGeAlD
Phylloquinone—GGCX—central nervous system—acquired immunodeficiency syndrome	0.0172	0.0681	CbGeAlD
Phylloquinone—Inflammation—Didanosine—acquired immunodeficiency syndrome	0.0167	0.0223	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0207	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Stavudine—acquired immunodeficiency syndrome	0.0155	0.0207	CcSEcCtD
Phylloquinone—Inflammation—Nevirapine—acquired immunodeficiency syndrome	0.015	0.0201	CcSEcCtD
Phylloquinone—Inflammation—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0194	CcSEcCtD
Phylloquinone—Inflammation—Stavudine—acquired immunodeficiency syndrome	0.0145	0.0194	CcSEcCtD
Phylloquinone—Inflammation—Abacavir—acquired immunodeficiency syndrome	0.0143	0.0191	CcSEcCtD
Phylloquinone—Necrosis—Efavirenz—acquired immunodeficiency syndrome	0.0137	0.0183	CcSEcCtD
Phylloquinone—GGCX—brain—acquired immunodeficiency syndrome	0.0136	0.0541	CbGeAlD
Phylloquinone—Hyperbilirubinaemia—Zidovudine—acquired immunodeficiency syndrome	0.0134	0.018	CcSEcCtD
Phylloquinone—GGCX—lymph node—acquired immunodeficiency syndrome	0.0132	0.0522	CbGeAlD
Phylloquinone—Necrosis—Delavirdine—acquired immunodeficiency syndrome	0.0131	0.0175	CcSEcCtD
Phylloquinone—Cyanosis—Saquinavir—acquired immunodeficiency syndrome	0.0129	0.0173	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Indinavir—acquired immunodeficiency syndrome	0.0125	0.0167	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.0122	0.0162	CcSEcCtD
Phylloquinone—Inflammation—Indinavir—acquired immunodeficiency syndrome	0.0117	0.0157	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Delavirdine—acquired immunodeficiency syndrome	0.0113	0.0151	CcSEcCtD
Phylloquinone—Inflammation—Efavirenz—acquired immunodeficiency syndrome	0.0111	0.0148	CcSEcCtD
Phylloquinone—Inflammation—Delavirdine—acquired immunodeficiency syndrome	0.0106	0.0142	CcSEcCtD
Phylloquinone—Phlebitis—Zidovudine—acquired immunodeficiency syndrome	0.0103	0.0138	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0134	CcSEcCtD
Phylloquinone—Inflammation—Saquinavir—acquired immunodeficiency syndrome	0.00943	0.0126	CcSEcCtD
Phylloquinone—Swelling—Indinavir—acquired immunodeficiency syndrome	0.00936	0.0125	CcSEcCtD
Phylloquinone—Inflammation—Lamivudine—acquired immunodeficiency syndrome	0.009	0.012	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.00853	0.0114	CcSEcCtD
Phylloquinone—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00846	0.0113	CcSEcCtD
Phylloquinone—Phlebitis—Ritonavir—acquired immunodeficiency syndrome	0.00801	0.0107	CcSEcCtD
Phylloquinone—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00757	0.0101	CcSEcCtD
Phylloquinone—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00754	0.0101	CcSEcCtD
Phylloquinone—Sweating increased—Zidovudine—acquired immunodeficiency syndrome	0.00747	0.00999	CcSEcCtD
Phylloquinone—Phlebitis—Lamivudine—acquired immunodeficiency syndrome	0.00735	0.00983	CcSEcCtD
Phylloquinone—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00661	0.00883	CcSEcCtD
Phylloquinone—Sweating increased—Efavirenz—acquired immunodeficiency syndrome	0.00657	0.00878	CcSEcCtD
Phylloquinone—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00656	0.00877	CcSEcCtD
Phylloquinone—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0064	0.00856	CcSEcCtD
Phylloquinone—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00637	0.00851	CcSEcCtD
Phylloquinone—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.00629	0.0084	CcSEcCtD
Phylloquinone—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.00628	0.0084	CcSEcCtD
Phylloquinone—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00617	0.00825	CcSEcCtD
Phylloquinone—Sweating—Indinavir—acquired immunodeficiency syndrome	0.0061	0.00815	CcSEcCtD
Phylloquinone—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00578	0.00773	CcSEcCtD
Phylloquinone—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.00576	0.0077	CcSEcCtD
Phylloquinone—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.00559	0.00747	CcSEcCtD
Phylloquinone—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00534	0.00714	CcSEcCtD
Phylloquinone—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.00533	0.00713	CcSEcCtD
Phylloquinone—Flushing—Indinavir—acquired immunodeficiency syndrome	0.0053	0.00708	CcSEcCtD
Phylloquinone—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.0052	0.00695	CcSEcCtD
Phylloquinone—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00516	0.00689	CcSEcCtD
Phylloquinone—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.0051	0.00681	CcSEcCtD
Phylloquinone—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00501	0.00669	CcSEcCtD
Phylloquinone—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00494	0.00661	CcSEcCtD
Phylloquinone—Pain—Didanosine—acquired immunodeficiency syndrome	0.00494	0.00661	CcSEcCtD
Phylloquinone—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00487	0.00651	CcSEcCtD
Phylloquinone—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00487	0.00651	CcSEcCtD
Phylloquinone—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00485	0.00649	CcSEcCtD
Phylloquinone—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.0047	0.00628	CcSEcCtD
Phylloquinone—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00468	0.00626	CcSEcCtD
Phylloquinone—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00462	0.00618	CcSEcCtD
Phylloquinone—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00449	0.00601	CcSEcCtD
Phylloquinone—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00449	0.006	CcSEcCtD
Phylloquinone—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00444	0.00594	CcSEcCtD
Phylloquinone—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00443	0.00592	CcSEcCtD
Phylloquinone—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00441	0.00589	CcSEcCtD
Phylloquinone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00436	0.00583	CcSEcCtD
Phylloquinone—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00431	0.00576	CcSEcCtD
Phylloquinone—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.0043	0.00575	CcSEcCtD
Phylloquinone—Pain—Stavudine—acquired immunodeficiency syndrome	0.00429	0.00574	CcSEcCtD
Phylloquinone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00426	0.00569	CcSEcCtD
Phylloquinone—Pain—Abacavir—acquired immunodeficiency syndrome	0.00423	0.00565	CcSEcCtD
Phylloquinone—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00422	0.00564	CcSEcCtD
Phylloquinone—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00415	0.00555	CcSEcCtD
Phylloquinone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00406	0.00542	CcSEcCtD
Phylloquinone—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.004	0.00535	CcSEcCtD
Phylloquinone—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00396	0.00529	CcSEcCtD
Phylloquinone—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00392	0.00524	CcSEcCtD
Phylloquinone—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00389	0.0052	CcSEcCtD
Phylloquinone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00383	0.00512	CcSEcCtD
Phylloquinone—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00382	0.0051	CcSEcCtD
Phylloquinone—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00373	0.00499	CcSEcCtD
Phylloquinone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00371	0.00496	CcSEcCtD
Phylloquinone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00371	0.00495	CcSEcCtD
Phylloquinone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.0037	0.00494	CcSEcCtD
Phylloquinone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00364	0.00487	CcSEcCtD
Phylloquinone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00362	0.00483	CcSEcCtD
Phylloquinone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00355	0.00474	CcSEcCtD
Phylloquinone—Pain—Indinavir—acquired immunodeficiency syndrome	0.00347	0.00464	CcSEcCtD
Phylloquinone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00343	0.00458	CcSEcCtD
Phylloquinone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00342	0.00457	CcSEcCtD
Phylloquinone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00333	0.00445	CcSEcCtD
Phylloquinone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00332	0.00444	CcSEcCtD
Phylloquinone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00328	0.00438	CcSEcCtD
Phylloquinone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00328	0.00438	CcSEcCtD
Phylloquinone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00327	0.00437	CcSEcCtD
Phylloquinone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00327	0.00437	CcSEcCtD
Phylloquinone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00317	0.00424	CcSEcCtD
Phylloquinone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00316	0.00422	CcSEcCtD
Phylloquinone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00314	0.00419	CcSEcCtD
Phylloquinone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00311	0.00416	CcSEcCtD
Phylloquinone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00305	0.00408	CcSEcCtD
Phylloquinone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00302	0.00404	CcSEcCtD
Phylloquinone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00301	0.00402	CcSEcCtD
Phylloquinone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00299	0.004	CcSEcCtD
Phylloquinone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00291	0.00389	CcSEcCtD
Phylloquinone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00291	0.00389	CcSEcCtD
Phylloquinone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.0029	0.00388	CcSEcCtD
Phylloquinone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00288	0.00386	CcSEcCtD
Phylloquinone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00282	0.00378	CcSEcCtD
Phylloquinone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00279	0.00373	CcSEcCtD
Phylloquinone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00278	0.00371	CcSEcCtD
Phylloquinone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.00361	CcSEcCtD
Phylloquinone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00268	0.00359	CcSEcCtD
Phylloquinone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00266	0.00356	CcSEcCtD
Phylloquinone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00253	0.00339	CcSEcCtD
Phylloquinone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.0025	0.00334	CcSEcCtD
Phylloquinone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00243	0.00324	CcSEcCtD
Phylloquinone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.00321	CcSEcCtD
Phylloquinone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00307	CcSEcCtD
Phylloquinone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00224	0.003	CcSEcCtD
Phylloquinone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00216	0.00289	CcSEcCtD
Phylloquinone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00206	0.00275	CcSEcCtD
